GMO PEPABO, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,341 JPY | +0.07% |
|
-1.32% | +14.71% |
| Feb. 13 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
| Feb. 13 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 12,545 | 30,351 | 13,541 | 9,868 | 6,169 | 7,077 | - |
| Enterprise Value (EV) 1 | 10,792 | 27,879 | 11,342 | 8,880 | 4,886 | 7,077 | 7,077 |
| P/E ratio | 23.2 x | 36.3 x | 18.9 x | 19.4 x | -9.81 x | 17.1 x | 13.7 x |
| Yield | 2.69% | 1.4% | 2.66% | 2.67% | - | 2.98% | 3.65% |
| Capitalization / Revenue | 1.4 x | 2.76 x | 1.14 x | 0.94 x | 0.57 x | 0.65 x | 0.63 x |
| EV / Revenue | 1.4 x | 2.76 x | 1.14 x | 0.94 x | 0.57 x | 0.65 x | 0.63 x |
| EV / EBITDA | - | 25,721,488 x | 11,421,921 x | 9,149,979 x | 54,164,138 x | - | - |
| EV / FCF | 21,628,580 x | 34,966,999 x | - | -10,225,979 x | 5,582,681 x | - | - |
| FCF Yield | 0% | 0% | - | -0% | 0% | - | - |
| Price to Book | 7.32 x | 12.1 x | 4.66 x | 3.67 x | 3.41 x | - | - |
| Nbr of stocks (in thousands) | 5,197 | 5,251 | 5,291 | 5,277 | 5,277 | 5,277 | - |
| Reference price 2 | 2,414 | 5,780 | 2,559 | 1,870 | 1,169 | 1,341 | 1,341 |
| Announcement Date | 3/31/20 | 2/3/21 | 2/7/22 | 2/6/23 | 2/13/24 | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,943 | 11,014 | 11,879 | 10,531 | 10,903 | 10,933 | 11,320 |
| EBITDA | - | 1,180 | 1,186 | 1,078 | 113.9 | - | - |
| EBIT 1 | 783 | 927 | 888 | 732 | -340 | 690 | 800 |
| Operating Margin | 8.76% | 8.42% | 7.48% | 6.95% | -3.12% | 6.31% | 7.07% |
| Earnings before Tax (EBT) | 720 | 1,234 | 1,065 | 771 | -395 | - | - |
| Net income 1 | 542 | 829 | 715 | 510 | -628 | 415 | 518 |
| Net margin | 6.06% | 7.53% | 6.02% | 4.84% | -5.76% | 3.8% | 4.58% |
| EPS 2 | 104.1 | 159.1 | 135.2 | 96.37 | -119.2 | 78.60 | 98.20 |
| Free Cash Flow | 580 | 868 | - | -965 | 1,105 | - | - |
| FCF margin | 6.49% | 7.88% | - | -9.16% | 10.13% | - | - |
| FCF Conversion (EBITDA) | - | 73.56% | - | - | 970.22% | - | - |
| FCF Conversion (Net income) | 107.01% | 104.7% | - | - | - | - | - |
| Dividend per Share 2 | 65.00 | 81.00 | 68.00 | 50.00 | - | 40.00 | 49.00 |
| Announcement Date | 3/31/20 | 2/3/21 | 2/7/22 | 2/6/23 | 2/13/24 | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 Q3 | 2022 Q1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 5,352 | 5,950 | 3,008 | 2,535 | 5,106 | 2,703 | 2,735 | 5,523 | 2,702 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT | 623 | 459 | 247 | 225 | 248 | 322 | 36 | -825 | 243 | - |
| Operating Margin | 11.64% | 7.71% | 8.21% | 8.88% | 4.86% | 11.91% | 1.32% | -14.94% | 8.99% | - |
| Earnings before Tax (EBT) | 652 | 567 | 269 | 248 | 268 | 342 | 104 | -746 | 242 | - |
| Net income | 394 | 362 | 171 | 170 | 182 | 236 | 41 | -892 | 168 | - |
| Net margin | 7.36% | 6.08% | 5.68% | 6.71% | 3.56% | 8.73% | 1.5% | -16.15% | 6.22% | - |
| EPS | 75.65 | 68.50 | 32.43 | 32.05 | 34.45 | 44.56 | 7.840 | -169.1 | 31.84 | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 7/29/20 | 8/6/21 | 11/8/21 | 5/9/22 | 8/4/22 | 11/7/22 | 5/8/23 | 8/9/23 | 11/13/23 | 2/13/24 |
1JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 1,753 | 2,472 | 2,199 | 988 | 1,283 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | 580 | 868 | - | -965 | 1,105 | - | - |
| ROE (net income / shareholders' equity) | 31.6% | 39.2% | 26.3% | 18.2% | -27.9% | 20.6% | 21.8% |
| ROA (Net income/ Total Assets) | - | 13.5% | 11.3% | 7.55% | -2.21% | - | - |
| Assets 1 | - | 6,149 | 6,308 | 6,751 | 28,476 | - | - |
| Book Value Per Share | 330.0 | 477.0 | 549.0 | 510.0 | 343.0 | - | - |
| Cash Flow per Share | 147.0 | 207.0 | 191.0 | 162.0 | -33.00 | - | - |
| Capex | 118 | 385 | 479 | 752 | 674 | - | - |
| Capex / Sales | 1.32% | 3.5% | 4.03% | 7.14% | 6.18% | - | - |
| Announcement Date | 3/31/20 | 2/3/21 | 2/7/22 | 2/6/23 | 2/13/24 | - | - |
1JPY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.71% | 46.28M | |
| +25.14% | 434B | |
| +18.99% | 250B | |
| +12.44% | 144B | |
| +17.31% | 101B | |
| +23.22% | 88.78B | |
| +57.56% | 58.93B | |
| +15.09% | 46.54B | |
| +4.39% | 37.25B | |
| +20.16% | 35.9B |
- Stock Market
- Equities
- 3633 Stock
- Financials GMO Pepabo, Inc.